Mid-regional pro-adrenomedullin is an independent predictor of cardiovascular outcomes in cardiac surgery, a prospective cohort study in 500 patients
Event:
ESC Congress 2024
Topic:
Arrhythmias
Session:
Optimising clinical outcomes after cardiac surgery